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Abstract 
 
The entity of atypical squamous cells of undetermined significance (ASCUS) in The Bethesda System 2001 for reporting cervical 
cytology is characterized by equivocal diagnosis, poor reproducibility and debatable management. This retrospective study was done 
to analyse the causes of false ASCUS if any and identify the educational needs as part of quality assurance programme. Cervical 
smears of all ASCUS cases reported over the one-year period were reviewed by the Cytopathologist. Relevant clinical data was 
retrieved. ASCUS was the most common type of abnormality representing 43.0 % cases among 294 abnormal smears reported during 
study period. 16.0% cases were found to be non ASCUS on review. The main four causes of over use of ASCUS diagnosis were poor 
quality smears and cellular atypia associated with Candida infection, atrophy and squamous metaplasia. Educational measures are 
being undertaken to avoid over diagnosis and improve the patient management (Afr J Reprod Health 2011; 15[1]: 111-114). 
 
Résumé 
 
Causes des fausses cellules de l’épithélium atypique d’un diagnostic d’une signification inconnue et le besoin éducatif dans un 
Centre Hospitalier Universitaire. L’entité des cellules de l’épithélium atypique d’une signification non déterminée(CEAS) dans le 
système Bethesda 2001 destiné à la déclaration de la cytologie cervicale est caractérisée par le diagnostic équivoque, une mauvaise 
reproductivité et un traitement discutable.  Cette étude rétrospective a été faite pour analyser les causes des fausses CEAS, si cela 
existe, et d’identifier les besoins éducatifs comme faisant partie du programme de l’assurance de qualité.  Le Cytopathologue a passé 
en revue tous les frottis de tous les cas de la CEAS qui ont été déclarés au cours d’une année.  Les données cliniques nécessaires ont 
été rétablies.  La CEAS était l’anomalie la plus commune, ce qui représente 43,0% parmi les 294 frottis anomaux qui ont été déclarés 
au cours de la période de l’étude.  A la revue, on a découvert que 16,0% n’étaient pas des CEAS.  Les quatre causes principales du 
suremploi du diagnostic de la CEAS étaient la mauvaise qualité du frottis et l’atypie cellulaire liée à l’infection candidose, l’atrophie 
et la métaplasie squameuse. On prend des mesures éducatives pour éviter le surdiagnostic et pour améliorer le traitement de la 
patiente (Afr J Reprod Health 2011; 15[1]: 111-114). 
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Introduction 
 
The entity of atypical squamous cells of undetermined 
significance (ASCUS) in The Bethesda System (TBS) 
2001 for reporting cervical cytology (also known as Pap 
smears) is characterized by equivocal diagnosis, poor 
reproducibility and debatable management.1,2 Therefore it 
is a challenge to the pathologist and clinician alike and 
stressful for the patient.  
Our cytology laboratory is attached to the University 
Hospital and receives Pap smears collected in outpatient 
departments of our hospital and those sent by clinical 
officers, general practitioners, physicians and 
gynecologists from other private hospitals, clinics and 
laboratories. All cases are screened initially by the 
residents and then reported in consultation with the 
faculty (two tier screening). 
 
The present study was done to analyse the causes of false 
ASCUS if any and identify the educational needs for the 
residents and pathologists as part of quality assurance 
programme of our lab. The aim is to propose measures to 
improve the efficacy of cervical cytology screening. In 
Kenya, there is only opportunistic screening of the 
women visiting any out- patient clinic for gynecological 
or unrelated conditions and asymptomatic women who 
request it. 
 
Methods 
 
The laboratory records of all abnormal Pap smears were 
reviewed for the one-year period from January 1, 2009 to 
December 31, 2009. Relevant clinical data and follow up 
cytology or histology (where available) for all ASCUS 
cases was retrieved. No reflex Human Papillomavirus 
(HPV) testing is done in our lab. The cytopathologist 
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(NK) with experience of 25 years reviewed all the smears 
reported as ASCUS.  
 
Results 
 
A total of 6,500 Pap smears were screened during the 
study period out of which 294 (4.5%) were reported 
abnormal. ASCUS was the most common type of 
abnormal pap smear result representing 43.0 % (126) 
cases among all abnormal pap smears. The diagnosis of 
squamous intraepithelial lesion (SIL) including low grade 
SIL and high grade SIL was given in 30.6% (90) and 
16.3% (48) cases, respectively. The remaining 10.1% 
(30) cases included atypical glandular cells, endometrial 
cells in women above 40 years of age and 
adenocarcinoma.  The ASCUS and SIL (including low 
and high grade) ratio was 0.9.  
The age range of women with ASCUS diagnosis was 
21–63 years (mean age 32 years). Table 1 shows the 
distribution of all women with ASCUS diagnosis in 
different age groups. The maximum percentage 62.0% 
(78 out of 126) of women was in the age group of 30-45 
years.  
 
Age range Number of women (%) 
21-29 years 18 ((14.0) 
30-45 years 78 (62.0) 
45-55 years 24 (19.0) 
>55 years   6 (5.0) 
 
In 78.6% (99 out of 126) women no clinical data was 
available and this could include both symptomatic and 
asymptomatic women for routine pap smears. The 
clinical profile was available only in 21.4% (27 out of 
126) women with ASCUS diagnosis. The previous 
diagnosis of ASCUS, low grade SIL and high grade SIL 
was available in 37.0 % (10), 14.8% (4) and 7.4 % (2) 
respectively. Past history of LEEP was available in 18.5 
% (5) women. In addition 18.5 % (5) had presented with 
bleeding and 11.1% (3) had vaginal discharge. Positive 
HIV status was mentioned in 30.0% (8 cases) only.  
On review of all ASCUS smears none of the above 
mentioned significant history appeared to be the cause of 
false diagnosis of ASCUS in our series. Only 23.8% (30 
out of 126) cases were found to be non ASCUS in 
women with no significant past history.  These were 
diagnosed as normal in 10.0% (3 out of 30) cases, 
inflammation with Candida infection in 13.3% (4) cases, 
atypia in atrophic smear of 20.0% ( 6) post menopausal, 
6.7% (2)  post partum women and 16.7% (5) women with 
prolonged use of  injectable Depo provera. Twenty 
percent (6) were considered unsatisfactory due to poor 
quality smears and 13.3% (4) were immature squamous 
metaplasia. None of the case was upgraded to SIL or 
squamous cell carcinoma (SCC).  
The follow-up cervical biopsy done within 2 months 
of Pap test was available for only 16.0% (20 out of 126) 
cases with initial ASCUS result. The biopsy was normal 
in 75.0 % (15) cases. CIN 1 was diagnosed in 15.0% (3) 
cases. One case each was diagnosed as CIN 3 and SCC. 
Pap smears of these cases were confirmed to be ASCUS 
on review. There was no follow up biopsy for cases 
considered false ASCUS on review.  
 
Discussion 
 
ASCUS is defined as a cellular abnormality that is more 
marked than those attributable to reactive changes but 
that quantitatively or qualitatively falls short of a 
definitive diagnosis of SIL. 2 On follow up ASCUS may 
resolve naturally or show an exuberant reactive change or 
SIL or SCC on cervical biopsy. The overuse of follow-up 
procedures may increase the expense and morbidity of 
unnecessary treatment.3  
It is particularly a matter of concern in low resource 
settings like sub Saharan Africa having high risk 
populations with high incidence and prevalence of cancer 
cervix and HIV. The problem is further compounded by 
the lack of an organized screening programme, lack of 
trained cytopathologists and cytoscreeners and lack of 
facilities for HPV testing. There is fear among 
pathologists of missing an abnormality due to the higher 
prevalence of risk factors in this population, the lack of 
timely follow-up of abnormal pap smears in view of the 
opportunistic screening, the non availability of records or 
patient information to enable rescreening of previous pap 
smears. 4  
All of the above raises important quality assurance 
issues. It is currently recommended that laboratory rates 
of ASCUS should be less than 5.0 % in low-risk 
populations and less than 2 to 3 times the SIL rate in 
high-risk populations.3 It was less than one in our study 
and well within the recommended range.  
High risk patient profile such as HIV positive, 
previous ASCUS or antecedent SIL, previously treated 
for SIL are more likely to get an ASCUS report. 3  
However in our study this did not reflect over diagnosis 
of ASCUS. The clinical information was not available in 
79.0% women and is the main limitation of this study in 
addition to poor follow up information.  
Educational sessions for the clinicians are being 
conducted and emphasis is given on the critical steps to 
obtain good quality smears and importance of adequate 
and necessary information on the laboratory requisition 
forms. A user friendly request form with a checklist of 
the minimum essential data has been developed and is 
now in use. Educational session was conducted for 
clinicians and other personnel such as nurses and 
residents involved in filling the request form.   
Presence of air drying, thick poorly spread smear, 
hemorrhagic smear, superimposed or crushed nuclei and 
dense inflammation obscuring morphology can result in 
over diagnosis of ASCUS. 3,5  Upon reevaluation, 
ASCUS in  5.0 % (6 out of 126) of our cases should have 
been labeled unsatisfactory due to poor quality smears. A 
rescreening diagnosis of HSIL or invasive carcinoma for 
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a smear originally reported as ASCUS is serious error but 
was not seen in any of our cases.  
Nuclear changes are critical for making the ASCUS 
diagnosis and include chromasia, chromatin texture, 
nuclear shape and size, and nucleolus. The squamous cell 
with nuclear enlargement of 2.5 to 3 times the size of 
intermediate squamous cell nucleus is classified as 
ASCUS. 2 However visual comparison of nuclear size of 
ASCUS from intermediate cell nucleus is imperfect with 
low accuracy.6 This is an unavoidable cause of over or 
under diagnosis of ASCUS.  Different observers give 
preference to different criteria and have different 
threshold. 
The important potential implication of this study is 
that the causes of false ASCUS identified in this study 
can be avoided with educational measures that are 
already in place in our laboratory now. These include 
instructional tutorials for the pathologists and residents to 
use strict criteria of ASCUS and submitting for a second 
review to the cytopathologist for a possible ASCUS 
diagnosis in such cases. There is a "learning curve" which 
would gradually influence interpretive thresholds. 
Archiving of abnormal pap smears in the laboratory is 
improved and facilitated by manual recording of 
information about all abnormal pap smears and any 
follow up biopsy in a separate register. Upgrading of the 
laboratory information system to incorporate this 
information and facilitate easy retrieval has been 
recommended to the information technologist. 
In our series 3.0% of ASCUS cases were reassessed 
as benign with Candida infection. This can happen 
because of the generally unrecognized spectrum of 
Candida-associated changes. It needs to be emphasized in 
educational sessions that ASCUS of inflammation and 
infection such as trichomonas, candida, bacterial 
vaginosis or viral infection can cause transient mild 
nuclear atypia in cervical cells. This nuclear enlargement 
is only twice that of an intermediate squamous-cell 
nucleus. In addition other features of inflammation such 
as intense orangophilia may be misinterpreted as 
keratinizing dysplasia, vacuolated cytoplasm and/or 
perinuclear halo may be confused with HPV effect. 
Diligent search should be made to identify the organisms. 
This guides the clinician to prescribe proper medication 
for the infection, without costly follow-up. 3 
Atypia in smears showing atrophic pattern due to 
various causes (including 6 post menopausal and 2 post 
natal women and 5 women with prolonged use of 
Depoprovera) led to over diagnosis of ASCUS in 10.3% 
(13 out of 126) cases. ASCUS interpretation of reparative 
epithelial changes (immature squamous metaplasia) is a 
know pitfall and was seen in 13.3% cases. In atrophy and 
metaplasia, the nucleus of parabasal cells may be mildly 
hyperchromatic with slight increase in nuclear 
cytoplasmic ratio (nuclear enlargement less than 3 times 
of ICN), but show uniform nuclear spacing, even 
chromatin distribution, minimal nuclear pleomorphism 
and pseudokoilocytosis.7,8,9   
The recommendation in pap smear report on the use 
of estrogens in post-menopausal women, treatment of 
infection before the repeat smear, the use of reflex HPV 
test if affordable (only in women over 20) before referral 
to colposcopy can be further helpful.10 In our hospital 
most often 6 monthly follow-up with pap smears is 
recommended in the absence of HPV testing. In high risk 
patients (previously abnormal smear, poor compliance, 
immunosuppressed women etc.) the option of immediate 
colposcopy and biopsy is considered. 11 
To conclude, the main four causes of over use of 
ASCUS were poor quality smears, atypia in Candida 
associated inflammation, atrophy and immature 
squamous metaplasia. This was accompanied by lack of 
adequate and necessary information on the request forms 
in majority of cases. The educational measures are being 
undertaken to increase awareness among pathologists and 
clinicians to improve the patient management.  
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